Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

被引：4

作者：

Akyuz, Filiz ^{[1
]}

Polat, Nuray ^{[2
]}

Kaymakoglu, Sabahattin ^{[1
]}

Aksoy, Nevzat ^{[1
]}

Demir, Kadir ^{[1
]}

Besisik, Fatih ^{[1
]}

Badur, Selim ^{[2
]}

Cakaloglu, Yilmaz ^{[1
]}

Okten, Atilla ^{[1
]}

机构：

[1] Istanbul Univ, Istanbul Fac Med, Dept Gastroenterohepatol, TR-34590 Istanbul, Turkey

[2] Istanbul Univ, Istanbul Fac Med, Dept Microbiol, TR-34590 Istanbul, Turkey

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2005年 / 11卷 / 45期

关键词：

Liver cytokines; HCV; ALT;

D O I：

10.3748/wjg.v11.i45.7188

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AIM: To evaluate whether the cytokine responses in liver and serum differ in chronic hepatitis C patients with normal and high alanine aminotransferase (ALT) levels. METHODS: Thirty-three (16 with normal ALT level as group 1 and 17 with elevated ALT level as group 2) patients infected with genotype 1b hepatitis C virus (HCV) were examined. Liver infiltrating lymphomononuclear cells (LILMCs) were isolated from liver biopsy by collagenase type 1 and stimulated with phytohemagglutinin and interleukin 2 (IL-2). IL-10, IL-12, interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) were determined in serum and LILMCs by ELISA. RESULTS: Serum cytokine levels were similar in both groups (P > 0.05). Stimulated IFN-gamma and TNF-alpha levels in LILMCs were increased in both groups. IL-12 and IL-10 levels stimulated with IL-2 were higher in group 1 than in group 2 (P = 0.023). Histological activity index (HAI) and stage had a negative correlation with TNF-alpha and IFN-gamma levels in group 2. CONCLUSION: Increased T-helper type 2 (Th2) cytokine response may regress inflammatory and biochemical activity. Progression of histological abnormalities in persons with elevated ALT probably depends on insufficient Th2 cytokine response, which does not balance Th1 cytokine response. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

引用

页码：7188 / 7191

页数：4

共 50 条

[21] Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection [J].

Goki Suda ;

Masayuki Kurosaki ;

Jun Itakura ;

Namiki Izumi ;

Yoshihito Uchida ;

Satoshi Mochida ;

Chitomi Hasebe ;

Masami Abe ;

Hiroaki Haga ;

Yoshiyuki Ueno ;

Ikuto Masakane ;

Kazumichi Abe ;

Atsushi Takahashi ;

Hiromasa Ohira ;

Ken Furuya ;

Masaru Baba ;

Yoshiya Yamamoto ;

Tomoe Kobayashi ;

Atsuhiko Kawakami ;

Kenichi Kumagai ;

Katsumi Terasita ;

Masatsugu Ohara ;

Naoki Kawagishi ;

Machiko Umemura ;

Masato Nakai ;

Takuya Sho ;

Mitsuteru Natsuizaka ;

Kenichi Morikawa ;

Koji Ogawa ;

Naoya Sakamoto .

Journal of Gastroenterology, 2019, 54 :78-86

[22] Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients [J].

Hosry, Jeff ;

Miranda, Roberto N. ;

Samaniego, Felipe ;

Economides, Minas P. ;

Torres, Harrys A. .

INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (05) :940-948

[23] Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients [J].

Hiroko Shindo ;

Shinya Maekawa ;

Kazuki Komase ;

Ryota Sueki ;

Mika Miura ;

Makoto Kadokura ;

Kuniaki Shindo ;

Fumitake Amemiya ;

Takatoshi Kitamura ;

Yasuhiro Nakayama ;

Taisuke Inoue ;

Minoru Sakamoto ;

Shun-ichi Okada ;

Yasuhiro Asahina ;

Namiki Izumi ;

Masao Honda ;

Shuichi Kaneko ;

Nobuyuki Enomoto .

Hepatology International, 2012, 6 :482-490

[24] Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients [J].

Shindo, Hiroko ;

Maekawa, Shinya ;

Komase, Kazuki ;

Sueki, Ryota ;

Miura, Mika ;

Kadokura, Makoto ;

Shindo, Kuniaki ;

Amemiya, Fumitake ;

Kitamura, Takatoshi ;

Nakayama, Yasuhiro ;

Inoue, Taisuke ;

Sakamoto, Minoru ;

Okada, Shun-ichi ;

Asahina, Yasuhiro ;

Izumi, Namiki ;

Honda, Masao ;

Kaneko, Shuichi ;

Enomoto, Nobuyuki .

HEPATOLOGY INTERNATIONAL, 2012, 6 (02) :482-490

[25] Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world [J].

Oh, Jae Young ;

Kim, Byung Seok ;

Lee, Chang Hyeong ;

Song, Jeong Eun ;

Lee, Heon Ju ;

Park, Jung Gil ;

Hwang, Jae Seok ;

Chung, Woo Jin ;

Jang, Byoung Kuk ;

Kweon, Young Oh ;

Tak, Won Young ;

Park, Soo Young ;

Jang, Se Young ;

Suh, Jeong Ill ;

Kwak, Sang Gyu .

KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04) :794-801

[26] Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir [J].

Krishnan, Preethi ;

Schnell, Gretja ;

Tripathi, Rakesh ;

Beyer, Jill ;

Reisch, Thomas ;

Zhang, Xinyan ;

Setze, Carolyn ;

Rodrigues, Lino, Jr. ;

Burroughs, Margaret ;

Redman, Rebecca ;

Chayama, Kazuaki ;

Kumada, Hiromitsu ;

Collins, Christine ;

Pilot-Matias, Tami .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) :1106-1113

[27] Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93 [J].

Ishigami, Masatoshi ;

Hayashi, Kazuhiko ;

Honda, Takashi ;

Kuzuya, Teiji ;

Ishizu, Yoji ;

Ishikawa, Tetsuya ;

Nakano, Isao ;

Urano, Fumihiro ;

Kumada, Takashi ;

Yoshioka, Kentaro ;

Hirooka, Yoshiki ;

Goto, Hidemi .

JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (04) :736-744

[28] In vitro basal T-cell proliferation among asymptomatic Human T cell Leukemia Virus type 1 patients co-infected with hepatitis C and/or Human Immunodeficiency Virus type 1 [J].

Assone, Tatiane ;

Kanashiro, Tatiana M. ;

Baldassin, Maira P. M. ;

Paiva, Arthur ;

Haziot, Michel E. ;

Smid, Jerusa ;

de Oliveira, Augusto Penalva ;

Fonseca, Luiz Augusto M. ;

Norris, Philip J. ;

Casseb, Jorge .

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (02) :106-112

[29] Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load [J].

Sezaki, Hitomi ;

Suzuki, Fumitaka ;

Kawamura, Yusuke ;

Yatsuji, Hiromi ;

Hosaka, Tetsuya ;

Akuta, Norio ;

Kobayashi, Masahiro ;

Suzuki, Yoshiyuki ;

Arase, Yasuji ;

Ikeda, Kenji ;

Kumada, Hiromitsu .

HEPATOLOGY RESEARCH, 2007, 37 (10) :787-792

[30] Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels [J].